vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and COMSCORE, INC. (SCOR). Click either name above to swap in a different company.
COMSCORE, INC. is the larger business by last-quarter revenue ($93.5M vs $62.1M, roughly 1.5× Cytek Biosciences, Inc.). COMSCORE, INC. runs the higher net margin — 3.2% vs -70.9%, a 74.2% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -1.5%). COMSCORE, INC. produced more free cash flow last quarter ($2.9M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 3.8%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Comscore, Inc. is an American-based global media measurement and analytics company providing marketing data and analytics to enterprises, advertising agencies, brand marketers, and publishers.
CTKB vs SCOR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $93.5M |
| Net Profit | $-44.1M | $3.0M |
| Gross Margin | 52.9% | 41.0% |
| Operating Margin | -9.0% | 7.0% |
| Net Margin | -70.9% | 3.2% |
| Revenue YoY | 8.1% | -1.5% |
| Net Profit YoY | -557.1% | -3.7% |
| EPS (diluted) | — | $9.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $93.5M | ||
| Q3 25 | $52.3M | $88.9M | ||
| Q2 25 | $45.6M | $89.4M | ||
| Q1 25 | $41.5M | $85.7M | ||
| Q4 24 | $57.5M | $94.9M | ||
| Q3 24 | $51.5M | $88.5M | ||
| Q2 24 | $46.6M | $85.8M | ||
| Q1 24 | $44.9M | $86.8M |
| Q4 25 | $-44.1M | $3.0M | ||
| Q3 25 | $-5.5M | $453.0K | ||
| Q2 25 | $-5.6M | $-9.5M | ||
| Q1 25 | $-11.4M | $-4.0M | ||
| Q4 24 | $9.6M | $3.1M | ||
| Q3 24 | $941.0K | $-60.6M | ||
| Q2 24 | $-10.4M | $-1.7M | ||
| Q1 24 | $-6.2M | $-1.1M |
| Q4 25 | 52.9% | 41.0% | ||
| Q3 25 | 52.7% | 40.6% | ||
| Q2 25 | 52.3% | 40.6% | ||
| Q1 25 | 48.6% | 39.6% | ||
| Q4 24 | 58.5% | 42.4% | ||
| Q3 24 | 56.3% | 41.2% | ||
| Q2 24 | 54.6% | 39.5% | ||
| Q1 24 | 51.3% | 42.3% |
| Q4 25 | -9.0% | 7.0% | ||
| Q3 25 | -17.6% | 1.9% | ||
| Q2 25 | -23.3% | -1.9% | ||
| Q1 25 | -36.1% | -2.4% | ||
| Q4 24 | 5.2% | 4.1% | ||
| Q3 24 | -8.2% | -67.4% | ||
| Q2 24 | -18.3% | -2.2% | ||
| Q1 24 | -23.9% | -2.2% |
| Q4 25 | -70.9% | 3.2% | ||
| Q3 25 | -10.5% | 0.5% | ||
| Q2 25 | -12.2% | -10.6% | ||
| Q1 25 | -27.5% | -4.7% | ||
| Q4 24 | 16.8% | 3.3% | ||
| Q3 24 | 1.8% | -68.5% | ||
| Q2 24 | -22.4% | -2.0% | ||
| Q1 24 | -13.8% | -1.2% |
| Q4 25 | — | $9.50 | ||
| Q3 25 | — | $-0.86 | ||
| Q2 25 | — | $-2.73 | ||
| Q1 25 | — | $-1.66 | ||
| Q4 24 | — | $-0.47 | ||
| Q3 24 | — | $-12.79 | ||
| Q2 24 | — | $-1.19 | ||
| Q1 24 | — | $-1.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $23.6M |
| Total DebtLower is stronger | — | $41.5M |
| Stockholders' EquityBook value | $341.7M | $111.4M |
| Total Assets | $461.5M | $407.7M |
| Debt / EquityLower = less leverage | — | 0.37× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $23.6M | ||
| Q3 25 | $93.3M | $26.7M | ||
| Q2 25 | $75.5M | $26.0M | ||
| Q1 25 | $95.3M | $31.0M | ||
| Q4 24 | $98.7M | $29.9M | ||
| Q3 24 | $162.3M | $20.0M | ||
| Q2 24 | $177.9M | $14.7M | ||
| Q1 24 | $168.8M | $18.7M |
| Q4 25 | — | $41.5M | ||
| Q3 25 | — | $41.4M | ||
| Q2 25 | — | $41.3M | ||
| Q1 25 | — | $41.3M | ||
| Q4 24 | — | $41.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $341.7M | $111.4M | ||
| Q3 25 | $378.6M | $-26.3M | ||
| Q2 25 | $377.6M | $-21.7M | ||
| Q1 25 | $379.6M | $-13.5M | ||
| Q4 24 | $395.7M | $-8.3M | ||
| Q3 24 | $385.5M | $-2.7M | ||
| Q2 24 | $389.1M | $45.8M | ||
| Q1 24 | $392.6M | $51.4M |
| Q4 25 | $461.5M | $407.7M | ||
| Q3 25 | $494.9M | $406.9M | ||
| Q2 25 | $493.3M | $415.9M | ||
| Q1 25 | $482.6M | $421.5M | ||
| Q4 24 | $499.5M | $430.2M | ||
| Q3 24 | $491.2M | $412.5M | ||
| Q2 24 | $483.7M | $474.1M | ||
| Q1 24 | $492.1M | $477.7M |
| Q4 25 | — | 0.37× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $3.2M |
| Free Cash FlowOCF − Capex | $-1.8M | $2.9M |
| FCF MarginFCF / Revenue | -2.9% | 3.1% |
| Capex IntensityCapex / Revenue | 1.6% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 1.07× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $21.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $3.2M | ||
| Q3 25 | $-3.9M | $9.5M | ||
| Q2 25 | $108.0K | $932.0K | ||
| Q1 25 | $-125.0K | $9.1M | ||
| Q4 24 | $2.0M | $-10.0M | ||
| Q3 24 | $13.2M | $12.5M | ||
| Q2 24 | $6.2M | $8.7M | ||
| Q1 24 | $4.0M | $6.9M |
| Q4 25 | $-1.8M | $2.9M | ||
| Q3 25 | $-4.6M | $9.4M | ||
| Q2 25 | $-1.5M | $787.0K | ||
| Q1 25 | $-974.0K | $8.7M | ||
| Q4 24 | $1.1M | $-10.3M | ||
| Q3 24 | $12.2M | $12.4M | ||
| Q2 24 | $5.2M | $8.5M | ||
| Q1 24 | $3.4M | $6.6M |
| Q4 25 | -2.9% | 3.1% | ||
| Q3 25 | -8.7% | 10.5% | ||
| Q2 25 | -3.2% | 0.9% | ||
| Q1 25 | -2.3% | 10.1% | ||
| Q4 24 | 1.9% | -10.8% | ||
| Q3 24 | 23.7% | 14.0% | ||
| Q2 24 | 11.0% | 10.0% | ||
| Q1 24 | 7.6% | 7.6% |
| Q4 25 | 1.6% | 0.3% | ||
| Q3 25 | 1.3% | 0.1% | ||
| Q2 25 | 3.5% | 0.2% | ||
| Q1 25 | 2.0% | 0.4% | ||
| Q4 24 | 1.6% | 0.2% | ||
| Q3 24 | 2.0% | 0.1% | ||
| Q2 24 | 2.3% | 0.2% | ||
| Q1 24 | 1.3% | 0.3% |
| Q4 25 | — | 1.07× | ||
| Q3 25 | — | 20.96× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | -3.19× | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
SCOR
| Transferred Over Time | $77.1M | 83% |
| Research Insight Solutions | $14.6M | 16% |
| Related Party | $2.5M | 3% |
